Bronek Pytowski

Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.

U. Rodeck, Yan Wu, K. Busam, 2009, Cancer Research.

Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages.

Don Yuen, Lu Chen, Bronek Pytowski, 2011, Investigative ophthalmology & visual science.

Tumor necrosis factor-alpha and interleukin-1 antagonists alleviate inflammatory skin changes associated with epidermal growth factor receptor antibody therapy in mice.

U. Rodeck, Yan Wu, K. Busam, 2009, Cancer research.